Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
Clinical trial NCT05371093 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05371093
- Sponsor
- Kite, A Gilead Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-22
- Primary completion
- 2030-10-01
- Enrollment
- 231
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.